期刊文献+

相转移催化合成4-{2-[N-甲基-N-(2-吡啶基)]氨基乙氧基}苯甲醛

Synthesis of 4-{ 2-[N-methyl-N-( 2-pyridyl) ]aminoethoxy} benzaldehyde by phase-transfer catalysis
下载PDF
导出
摘要 以2-氯吡啶(1)、2-甲氨基乙醇(2)和4-氟苯甲醛(4)为主要原料,经2步反应合成了4-{2-[N-甲基-N-(2-吡啶基)氨基乙氧基]}苯甲醛(5)。第1步反应n(2)∶n(1)=4∶1,反应温度160℃,反应时间约6 h,采用减压蒸馏进行后处理,2-[N-甲基-N-(2-吡啶基)氨基]乙醇(3)的收率在93%以上,过量2的回收率在97%以上,回收的2可以重复使用。第2步反应用氢氧化钠做碱性试剂,用甲苯和水分别做为两相的溶剂,在相转移催化剂CTAB作用下进行,经优化后5的收率可达90%以上。2步反应总收率达83%以上。 4 - { 2 - [ N-Methyl-N- (2-pyridyl) ] aminoethoxy t benzaldehyde (5) was synthesized by a two-steps process with 2-chloropyr- idine ( 1 ), 2- (methylamino) ethanol ( 2 ), and 4-fluorobenzaldehyde ( 4 ) as principal raw materials. In first step of the process, the mole ratio of 2 to 1 was 4:1, reaction temperature 160℃, reaction time about 6 h, and adopted vacuum distillation in work-up proce- dure. Under such conditions, the yield of 2- [ N-methyl-N- (2-pyridyl) amino ] ethanol (3) was more than 93 %, the rate of recovery of the excess 2 was more than 97% ,and recovered 2 could be cyclically used. The second step of process was carried out with sodium hydroxide as basic reagent, toluene and water as solvent of two phases respectively, CTAB as phase-transfer catalyst, gave 5 in more than 90% yield under optimal conditions. The above two steps gave 5 in more than 83% overall yield.
出处 《化学研究与应用》 CAS CSCD 北大核心 2012年第4期569-573,共5页 Chemical Research and Application
基金 安阳市2010年科技发展计划项目(10043)资助
关键词 相转移催化 4-{2-[N-甲基-N-(2-吡啶基)氨基乙氧基]}苯甲醛 2-[N-甲基-N-(2-吡啶基)氨基]乙醇 罗格列酮 phase-transfer catalysis 4-12- [ N-methyl-N- (2-pyridyl) ] aminoethoxy } benzaldehyde 2- [ N-methyl-N- (2-pyridyl) ami-no ] ethanol rosiglitazone
  • 相关文献

参考文献10

  • 1Sorbera L A,Rabasseda X,Castaner J,et al.Rosiglitazonemaleate[J].Drug of the Further,1998,23(9):977-985.
  • 2Cantello B C C,Cawthorne M A,Cottam G P,et al.[[ω-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinedio-nes as potent antihyperglycemic agents[J].J Med Chem,1994,37(23):3977-3985.
  • 3Cantello B C C,Cawthorne M A,Haigh D,et al.The syn-thesis of BRL 49653-A novel and potent antihyperglycemicagent[J].Bioorg Med Chem Lett,1994,4(10):1181-1184.
  • 4付晔,王绍杰,张为革,许越.马来酸罗格列酮的合成工艺改进[J].沈阳药科大学学报,2001,18(1):18-19. 被引量:3
  • 5Fischer J,Fodor T,Lévai S,et al.Antidiabetic thiazolidine-diones and their preparation[P].WO:0144240,2001-06-21.
  • 6Vyas S K.Process for the preparation of pyridine deriva-tive[P].US:20020115866,2002-08-22.
  • 7王恩思,王俊才,姜作辉,王家鹏.马来酸罗格列酮的合成[J].吉林大学自然科学学报,2000(3):68-72. 被引量:5
  • 8Chmielewski M K,Marchán V,Cies'lak J,et al.Thermo-lytic carbonates for potential 5'-hydroxyl protection of de-oxyribonucleosides[J].J Org Chem,2003,68(26):10003-10012.
  • 9Ambalai M I,Chandrakant S M,Rameshkumar S K,et al.An improved process for the preparation of 4-[2-(methyl-2-pyridinylamino)ethoxy]benzaldehyde,an intermediatefor the preparation of rosiglitazone[P].EP:1905761,2008-04-02.
  • 10LI Xin,Abell C,Warrington B H,et al.Polymer-assistedsolution phase synthesis of the antihyperglycemic agentRosiglitazone[J].Org Biomol Chem,2003,1(26):4392-4395.

二级参考文献5

  • 1[2]Barrie CC Cantello,Michael A Cawthorne,Graham P Cottam, et al.[[ω-(Heterocyclylamino) alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents [J]. Med Chem, 1994,37:3977-3985.
  • 2[3]Richard M Hindley.Preparation of 5-[[(heterocyclylamino)ethoxy]benzylidene]-2,4 - thiazolidinediones asantihyperglycemics and antihyperlipidemics [P]. US Patent: 5002953.1991-03-26(CA 115:49719y).
  • 3[4]Pool Colin Ripley,Roman Robin sherwood,Briyhwell Malcolom David,et al.Thiazolidinedione derivatives[P].WO Patent:9405,659.1994-03-17(CA 120:323564c).
  • 4[1]Sorbera LA, Rabasseda X, Castaner J,et al. Rosiglitazone Maleate [J].Drug of the Future,1998,23(9):977-985.
  • 5王恩思,段海峰,金磊.新型抗糖尿病药物曲格列酮的合成[J].吉林大学自然科学学报,1999(4):85-90. 被引量:3

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部